Skip to main content

Anfield Capital Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1602020 IRVINE, CA

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,339
-$21 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Anfield Capital Management, LLC holds $4,283,063 across 7 Biotechnology names. VRTX ranks #6 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
3 $1,339

All Filings in VRTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,339 3
2025-12-31 $1,360 3
2025-09-30 $1,174 3
2024-12-31 $1,198,837 2,977
2024-09-30 $1,384,543 2,977
2024-03-31 $1,076,793 2,576
2023-06-30 $916,373 2,604
2022-12-31 $153,630 532
2022-09-30 $359,898 1,243
2022-06-30 $338,148 1,200
2022-03-31 $268,277 1,028
2021-12-31 $96,624 440
2021-09-30 $7,255 40